About Us · Mind Medicine Australia
Mind Medicine Australia logo
Donate

About Us

Mind Medicine Australia is a registered charity working to alleviate the suffering and suicides caused by mental illness by expanding treatment options through the safe, clinical use of psychedelic-assisted therapies to treat depression, trauma, addictions and other intractable conditions. MMA’s wholly clinical focus includes building a national ecosystem encompassing professional development for health practitioners through the world-leading Certificate in Psychedelic-Assisted Therapies (CPAT), patient access pathways, medicine supplies, regulatory and research advancements, clinical rollouts and widespread awareness and education. MMA made global history through their successful rescheduling applications for psilocybin and MDMA making Australia the first nation in the world to reschedule these medicines for clinical use in 2023.

MELBOURNE, AUSTRALIA – NewsWire Photos NOVEMBER 29, 2022: Peter Hunt and Tania de Jong pose in their office in Melbourne.
Picture: NCA NewsWire / Luis Enrique Ascui

Indications of success

Four key strategic areas

Inclusivity

Mind Medicine Australia is committed to creating a diverse and inclusive environment and is proud to be an equal opportunity employer. All qualified applicants receive consideration for employment without regard to race, colour, religion, gender, gender identity or expression, sexual orientation, national origin, genetics, disability, age, or veteran status. Mind Medicine Australia associated practitioners also offer an inclusive and safe place for patients to receive care. We respect and value the cultural differences between us.

Research

We support and fund clinical psychedelic research, conducted by independent institutions and affiliates.

Partnerships

By developing relationships between government, academic institutions, interest groups and regulatory bodies, Mind Medicine Australia aims to facilitate evidence-based change.

Education & Events

We educate the general public, medical and mental health practitioners, regulators, and other stakeholders on clinical psychedelic research and therapeutic application.

Training

Mind Medicine Australia will act as the interface between research and practice by translating clinical research into accredited therapist training protocols, such as with our Certificate in Psychedelic-Assisted Therapies (CPAT)™.

Registered Charity logo

Our achievements in the first 6 years

Key Achievements

 

Other Achievements

 

Training & Education

Public Awareness & Engagement

Sector Leadership & Stakeholder Engagement

Research, Events & Policy

 

Subscribe to our newsletter

Stay in touch with Mind Medicine Australia:

×